also called: QoE, financial due diligence, transaction advisory services
A quality of earnings review takes the seller’s reported profit apart and rebuilds it. It tests whether revenue is recurring or one-off, whether claimed addbacks are genuinely non-recurring or are simply costs the business will still have, whether margins are moving in the direction the seller says, how concentrated the customer base is, and what normalized working capital actually looks like.
That last point is where the money usually is. The working capital peg determines how much cash has to be left in the business at closing, and a peg set from an unexamined average can move the real price by a great deal without the headline number changing at all.
Sellers increasingly commission their own review before going to market. Done early, it finds the problems while there is still time to fix them, rather than having a buyer find them at the worst possible moment and reprice.
As a buyer, after the letter of intent and inside exclusivity, on any acquisition of consequence. As a seller, a year or more before you intend to go to market.
A fixed fee for a defined scope is common, scaled to the target’s size and the messiness of its records. Scope creep is normal and usually justified, because the messiness is itself a finding.
Skipping it on a deal that feels friendly, or accepting the seller’s adjusted EBITDA because the seller seems honest. Claimed addbacks are not earnings until someone independent has tested them, and this has nothing to do with the seller’s character.
Not an audit, not a valuation, and not a substitute for your own understanding of the business. It tests the numbers, not the strategy.
The Institute accepts no payment from any advisor, takes no fee tied to any transaction, and does not place or refer professionals for compensation. This entry describes a role, not a recommendation of any firm.